Few diagnoses carry the devastating weight of dementia, which heralds loss, decline and inevitable death. The condition is the biggest killer in the UK, and cases are set to soar. “One in three people ...

FT Adviser is fundraising for Alzheimer’s Society as part of Insurance United Against Dementia. On November 27 this year, the ...

Dementia is a pretty broad umbrella term, encompassing everything from Alzheimer’s disease to Lewy body dementia and Huntington’s disease. The most common forms are Alzheimer’s, vascular dementia, and ...

Alzheimer’s Society, Innovate UK and Challenge Works have launched the Longitude Prize on Dementia – a competition with a £4million prize fund to find innovators who can create ground-breaking ...

A dementia symptom could manifest itself while someone is walking about, and whilst experts warn this can become "worrying", ...

Are you an early career researcher looking to explore a research idea with a supervisor? Alzheimer’s Society Postdoctoral Fellowships are ideal for anyone early in their research career. We have ...

A cause close to Jack Draper's heart has gotten a generous gift from the world No. 15 this holiday season. The 22-year-old recently organized a charity walk down the Thames River in supprt of the ...

Regulatory authorities in the UK are being urged to speed their review of lecanemab (Leqembi, Eisai) after the US Food and Drug Administration (FDA) approved it for early-stage Alzheimer's disease.

A psychologist has explained precisely what 'mixed dementia' means in an effort to clarify a common misconception. Dr Kelynn Lee, CEO of the Dementia Care Hub, has dedicated her career to researching ...

Dementia represents a syndrome, or collection of symptoms, associated with the gradual deterioration of brain function ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease. For the first time, scientists have ...

Researchers say they have made an "exciting" breakthrough in treating Alzheimer's disease by developing a drug to prevent the build-up of toxic proteins in the brain. Researchers say they have sparked ...